Previously Known As : Sbi Pharma Fund
Sbi Healthcare Opportunities Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 27-01-2026
NAV ₹403.9(R) +0.18% ₹465.01(D) +0.19%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular -0.08% 22.38% 15.47% 19.16% 11.08%
Direct 0.95% 23.68% 16.71% 20.42% 12.31%
Nifty Pharma TRI 3.06% 21.22% 12.59% 14.93% 7.47%
SIP (XIRR) Regular -7.14% 13.2% 15.63% 18.06% 15.7%
Direct -6.16% 14.46% 16.88% 19.37% 16.92%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.22 0.65 1.07 6.07% 0.22
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
14.13% -15.67% -12.33% 0.78 10.12%
Fund AUM As on: 30/12/2025 4058 Cr

No data available

NAV Date: 27-01-2026

Scheme Name NAV Rupee Change Percent Change
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 254.44
0.4600
0.1800%
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 323.07
0.6200
0.1900%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 403.9
0.7300
0.1800%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 465.01
0.8900
0.1900%

Review Date: 27-01-2026

Beginning of Analysis

The 5 star rating shows an excellent past performance of the Sbi Healthcare Opportunities Fund in Pharma Fund. The Sbi Healthcare Opportunities Fund has a Jensen Alpha of 6.07% which is higher than the category average of 3.25%. Here the Sbi Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns. The Sbi Healthcare Opportunities Fund has a Sharpe Ratio of 1.22 which is higher than the category average of 1.08. Here the Sbi Healthcare Opportunities Fund has shown very good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Sbi Healthcare Opportunities Fund Return Analysis

The Sbi Healthcare Opportunities Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -3.54%, -7.32 and -7.71 in last one, three and six months respectively. In the same period the category average return was -4.54%, -6.79% and -7.61% respectively.
  • Sbi Healthcare Opportunities Fund has given a return of 0.95% in last one year. In the same period the Nifty Pharma TRI return was 3.06%. The fund has given 2.11% less return than the benchmark return.
  • The fund has given a return of 23.68% in last three years and rank 3rd out of eight funds in the category. In the same period the Nifty Pharma TRI return was 21.22%. The fund has given 2.46% more return than the benchmark return.
  • Sbi Healthcare Opportunities Fund has given a return of 16.71% in last five years and category average returns is 15.86% in same period. The fund ranked 2.0nd out of eight funds in the category. In the same period the Nifty Pharma TRI return was 12.59%. The fund has given 4.12% more return than the benchmark return.
  • The fund has given a return of 12.31% in last ten years and ranked 4.0th out of four funds in the category. In the same period the Nifty Pharma TRI return was 7.47%. The fund has given 4.84% more return than the benchmark return.
  • The fund has given a SIP return of -6.16% in last one year whereas category average SIP return is -5.84%. The fund one year return rank in the category is 10th in 13 funds
  • The fund has SIP return of 14.46% in last three years and ranks 3rd in 8 funds. Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has given the highest SIP return (17.05%) in the category in last three years.
  • The fund has SIP return of 16.88% in last five years whereas category average SIP return is 15.61%.

Sbi Healthcare Opportunities Fund Risk Analysis

  • The fund has a standard deviation of 14.13 and semi deviation of 10.12. The category average standard deviation is 15.33 and semi deviation is 10.66.
  • The fund has a Value at Risk (VaR) of -15.67 and a maximum drawdown of -12.33. The category average VaR is -16.12 and the maximum drawdown is -14.76. The fund has a beta of 0.77 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -3.62 -3.50
    -4.63
    		-6.50 | -3.37 2 | 13 Very Good
    3M Return % -7.56 -2.32
    -7.09
    		-9.39 | -4.89 8 | 13 Good
    6M Return % -8.18 -4.19
    -8.20
    		-9.74 | -6.55 7 | 13 Good
    1Y Return % -0.08 3.06
    0.36
    		-4.58 | 6.46 8 | 13 Good
    3Y Return % 22.38 21.22
    21.55
    		19.92 | 25.68 3 | 8 Good
    5Y Return % 15.47 12.59
    14.47
    		12.81 | 16.53 2 | 8 Very Good
    7Y Return % 19.16 14.93
    19.47
    		18.25 | 21.18 4 | 7 Good
    10Y Return % 11.08 7.47
    11.79
    		11.08 | 13.37 4 | 4 Poor
    15Y Return % 15.93 11.54
    15.05
    		13.54 | 15.93 1 | 3 Very Good
    1Y SIP Return % -7.14
    -7.08
    		-19.64 | -0.83 10 | 13 Average
    3Y SIP Return % 13.20
    12.22
    		8.18 | 16.00 3 | 8 Good
    5Y SIP Return % 15.63
    14.21
    		12.92 | 17.19 2 | 8 Very Good
    7Y SIP Return % 18.06
    17.26
    		16.21 | 19.41 2 | 7 Very Good
    10Y SIP Return % 15.70
    15.48
    		15.08 | 16.03 2 | 4 Good
    15Y SIP Return % 15.41
    15.10
    		14.03 | 15.87 2 | 3 Good
    Standard Deviation 14.13
    15.33
    		14.13 | 16.15 1 | 8 Very Good
    Semi Deviation 10.12
    10.66
    		9.75 | 11.19 2 | 8 Very Good
    Max Drawdown % -12.33
    -14.76
    		-16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67
    -16.12
    		-19.03 | -13.05 2 | 8 Very Good
    Average Drawdown % -4.60
    -4.98
    		-6.39 | -3.87 3 | 8 Good
    Sharpe Ratio 1.22
    1.08
    		0.95 | 1.35 2 | 8 Very Good
    Sterling Ratio 1.07
    0.94
    		0.85 | 1.07 2 | 8 Very Good
    Sortino Ratio 0.65
    0.58
    		0.51 | 0.70 2 | 8 Very Good
    Jensen Alpha % 6.07
    3.25
    		0.58 | 7.60 2 | 8 Very Good
    Treynor Ratio 0.22
    0.19
    		0.16 | 0.24 2 | 8 Very Good
    Modigliani Square Measure % 27.90
    25.01
    		22.41 | 29.62 2 | 8 Very Good
    Alpha % -0.54
    0.03
    		-2.19 | 4.93 4 | 8 Good
    Return data last Updated On : Jan. 27, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -3.54 -3.50 -4.54 -6.41 | -3.26 2 | 13 Very Good
    3M Return % -7.32 -2.32 -6.79 -9.11 | -4.62 8 | 13 Good
    6M Return % -7.71 -4.19 -7.61 -9.18 | -5.91 7 | 13 Good
    1Y Return % 0.95 3.06 1.66 -3.02 | 7.72 8 | 13 Good
    3Y Return % 23.68 21.22 22.98 21.53 | 26.75 3 | 8 Good
    5Y Return % 16.71 12.59 15.86 14.41 | 17.55 2 | 8 Very Good
    7Y Return % 20.42 14.93 20.92 19.45 | 22.47 5 | 7 Average
    10Y Return % 12.31 7.47 13.07 12.31 | 14.39 4 | 4 Poor
    1Y SIP Return % -6.16 -5.84 -18.45 | 0.37 10 | 13 Average
    3Y SIP Return % 14.46 13.64 9.78 | 17.05 3 | 8 Good
    5Y SIP Return % 16.88 15.61 14.52 | 18.22 2 | 8 Very Good
    7Y SIP Return % 19.37 18.71 17.57 | 20.53 2 | 7 Very Good
    10Y SIP Return % 16.92 16.77 16.22 | 17.07 2 | 4 Good
    Standard Deviation 14.13 15.33 14.13 | 16.15 1 | 8 Very Good
    Semi Deviation 10.12 10.66 9.75 | 11.19 2 | 8 Very Good
    Max Drawdown % -12.33 -14.76 -16.36 | -12.33 1 | 8 Very Good
    VaR 1 Y % -15.67 -16.12 -19.03 | -13.05 2 | 8 Very Good
    Average Drawdown % -4.60 -4.98 -6.39 | -3.87 3 | 8 Good
    Sharpe Ratio 1.22 1.08 0.95 | 1.35 2 | 8 Very Good
    Sterling Ratio 1.07 0.94 0.85 | 1.07 2 | 8 Very Good
    Sortino Ratio 0.65 0.58 0.51 | 0.70 2 | 8 Very Good
    Jensen Alpha % 6.07 3.25 0.58 | 7.60 2 | 8 Very Good
    Treynor Ratio 0.22 0.19 0.16 | 0.24 2 | 8 Very Good
    Modigliani Square Measure % 27.90 25.01 22.41 | 29.62 2 | 8 Very Good
    Alpha % -0.54 0.03 -2.19 | 4.93 4 | 8 Good
    Return data last Updated On : Jan. 27, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Sbi Healthcare Opportunities Fund NAV Regular Growth Sbi Healthcare Opportunities Fund NAV Direct Growth
    27-01-2026 403.9017 465.0089
    23-01-2026 403.174 464.1192
    22-01-2026 406.2672 467.6669
    21-01-2026 402.1148 462.8741
    20-01-2026 403.641 464.6178
    19-01-2026 412.5114 474.815
    16-01-2026 416.2543 479.0831
    14-01-2026 420.9345 484.4426
    13-01-2026 421.1063 484.6268
    12-01-2026 420.1561 483.5198
    09-01-2026 421.23 484.715
    08-01-2026 425.3481 489.44
    07-01-2026 430.9671 495.8918
    06-01-2026 428.658 493.221
    05-01-2026 423.9511 487.7916
    02-01-2026 424.5047 488.3876
    01-01-2026 420.9916 484.3323
    31-12-2025 421.4351 484.829
    30-12-2025 417.4669 480.2504
    29-12-2025 419.0633 482.0735

    Fund Launch Date: 01/Jan/1993
    Fund Category: Pharma Fund
    Investment Objective: To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
    Fund Description: An open-ended Equity Scheme investing in healthcare sector
    Fund Benchmark: S&P BSE HEALTHCARE Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.